US$ 21.34
aod9604 vs semaglutide AOD-9604 vs Tirzepatide: Comparing Metabolic Research Peptides AOD-9604 vs Semaglutide: Peptide Key
Description
Weeks 9-16: optimization phase With both compounds at optimal doses, the body composition changes become significant

This increases the risk of neural tube defects, such as spina bifida, developing in the unborn baby

SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome

Seems more of an indication of the level they might question
